Advertisement

Combined tomography and epithelial thickness mapping for diagnosis of keratoconus

Combined tomography and epithelial thickness mapping for diagnosis of keratoconus

Eur J Ophthalmol 2017; 27(2): 129 - 134

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.5301/ejo.5000850

Authors

Ronald H. Silverman, Raksha Urs, Arindam RoyChoudhury, Timothy J. Archer, Marine Gobbe, Dan Z. Reinstein

Abstract

Purpose

Scanning Scheimpflug provides information regarding corneal thickness and 2-surface topography while arc-scanned high-frequency ultrasound allows depiction of the epithelial and stromal thickness distributions. Both techniques are useful in detection of keratoconus. Our aim was to develop and test a keratoconus classifier combining information from both methods.

Methods

We scanned 111 normal and 30 clinical keratoconus subjects with Artemis-1 and Pentacam data. After selecting one random eye per subject, we performed stepwise linear discriminant analysis on a dataset combining parameters generated by each method to obtain classification models based on each technique alone and in combination.

Results

Discriminant analysis resulted in a 4-variable model (R2 = 0.740) based on Artemis data alone and a 4-variable model (R2 = 0.734) using Pentacam data alone. The combined model (R2 = 0.828) consisted of 3 Artemis- and 4 Pentacam-derived variables. The combined model R value was significantly higher than either model alone (p = 0.031, one-tailed). In cross-validation, Artemis had 100% sensitivity and 99.2% specificity, Pentacam had 97.3% sensitivity and 98.0% specificity, and the combined model had 97.3% sensitivity and 100% specificity.

Conclusions

Pentacam, Artemis, and combined models were all effective in distinguishing normal from clinical keratoconus subjects. From the standpoint of variance explained by the model (R2 values), the combined model was most effective. Application of the model to early and subclinical keratoconus will ultimately be required to assess the effectiveness of the combined approach.

Article History

Disclosures

Financial support: Supported in part by NIH grant EY019055 and an unrestricted grant to the Department of Ophthalmology of Columbia University from Research to Prevent Blindness.
Conflict of interest: Drs. Silverman and Reinstein have a proprietary interest in the Artemis technology (ArcScan, Inc., Morrison, CO, USA) and are the authors of relevant patents administered by the Cornell Center for Technology Enterprise and Commercialization, Ithaca, NY, USA. The remaining authors have no proprietary or financial interest in the materials presented herein.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  • Department of Ophthalmology, Columbia University Medical Center, New York, NY - USA
  • F.L. Lizzi Center for Biomedical Engineering, Riverside Research, New York, NY - USA
  • Department of Biostatistics, Columbia University Medical Center, New York, NY - USA
  • London Vision Clinic, London - UK
  • Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts, Paris - France

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.